Asahi Life Asset Management CO. LTD. Takes Position in Axon Enterprise, Inc (NASDAQ:AXON)

Asahi Life Asset Management CO. LTD. purchased a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 785 shares of the biotechnology company's stock, valued at approximately $413,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of AXON. Fourth Dimension Wealth LLC bought a new position in Axon Enterprise in the fourth quarter valued at about $30,000. Bartlett & CO. Wealth Management LLC lifted its holdings in Axon Enterprise by 132.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after acquiring an additional 33 shares during the period. Catalyst Capital Advisors LLC bought a new position in Axon Enterprise in the first quarter valued at about $32,000. Alpine Bank Wealth Management bought a new position in Axon Enterprise in the first quarter valued at about $40,000. Finally, Elequin Capital LP bought a new position in Axon Enterprise in the fourth quarter valued at about $46,000. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Trading Down 0.5%

Shares of NASDAQ AXON opened at $729.62 on Monday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.62 and a current ratio of 2.83. The business's 50 day moving average price is $752.67 and its 200-day moving average price is $641.14. Axon Enterprise, Inc has a fifty-two week low of $279.02 and a fifty-two week high of $830.21. The company has a market cap of $56.80 billion, a price-to-earnings ratio of 176.24, a PEG ratio of 83.99 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.07. Axon Enterprise had a return on equity of 5.81% and a net margin of 14.86%. The firm had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. During the same period in the prior year, the business posted $1.15 earnings per share. The company's revenue for the quarter was up 31.3% on a year-over-year basis. On average, sell-side analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts have weighed in on AXON shares. Barclays increased their target price on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a report on Friday, May 9th. Wolfe Research initiated coverage on Axon Enterprise in a research note on Monday, July 7th. They issued an "outperform" rating on the stock. Needham & Company LLC raised their price objective on Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a research note on Thursday, May 8th. Bank of America raised their price objective on Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a research note on Wednesday, June 4th. Finally, The Goldman Sachs Group raised their price objective on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research note on Wednesday, May 14th. One analyst has rated the stock with a sell rating, one has given a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat, Axon Enterprise currently has an average rating of "Moderate Buy" and an average target price of $699.55.

Insiders Place Their Bets

In other Axon Enterprise news, President Joshua Isner sold 905 shares of the company's stock in a transaction on Tuesday, June 17th. The stock was sold at an average price of $776.39, for a total value of $702,632.95. Following the completion of the sale, the president directly owned 268,735 shares in the company, valued at approximately $208,643,166.65. This represents a 0.34% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 1,300 shares of the company's stock in a transaction on Monday, May 19th. The stock was sold at an average price of $738.84, for a total value of $960,492.00. Following the completion of the sale, the director owned 4,829 shares of the company's stock, valued at $3,567,858.36. This represents a 21.21% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 44,642 shares of company stock worth $30,500,428. 5.70% of the stock is owned by company insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.